Guardian Pharmacy Services, Inc. (NYSE:GRDN) Insider Sells $1,310,218.56 in Stock

Guardian Pharmacy Services, Inc. (NYSE:GRDN - Get Free Report) insider Kendall Forbes sold 64,991 shares of Guardian Pharmacy Services stock in a transaction dated Wednesday, May 28th. The shares were sold at an average price of $20.16, for a total value of $1,310,218.56. Following the transaction, the insider now owns 203,906 shares of the company's stock, valued at $4,110,744.96. This trade represents a 24.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Kendall Forbes also recently made the following trade(s):

• On Tuesday, May 27th, Kendall Forbes sold 350,058 shares of Guardian Pharmacy Services stock. The stock was sold at an average price of $20.16, for a total value of $7,057,169.28.

Guardian Pharmacy Services Price Performance

Guardian Pharmacy Services stock traded up $0.49 during trading on Tuesday, hitting $21.78. The stock had a trading volume of 290,686 shares, compared to its average volume of 169,453. Guardian Pharmacy Services, Inc. has a 1 year low of $14.16 and a 1 year high of $26.91. The stock's 50 day moving average is $23.19 and its two-hundred day moving average is $22.01.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last posted its quarterly earnings data on Monday, May 12th. The company reported $0.21 EPS for the quarter, missing the consensus estimate of $0.22 by ($0.01). The company had revenue of $329.31 million during the quarter, compared to analyst estimates of $321.21 million. Sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 0.87 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on the company. Truist Financial restated a "buy" rating and issued a $28.00 target price (up previously from $25.00) on shares of Guardian Pharmacy Services in a research note on Monday, May 19th. Raymond James set a $28.00 target price on Guardian Pharmacy Services and gave the stock an "outperform" rating in a research note on Wednesday, May 14th. Finally, Wall Street Zen downgraded Guardian Pharmacy Services from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th.

Hedge Funds Weigh In On Guardian Pharmacy Services

Several institutional investors have recently bought and sold shares of the company. R Squared Ltd purchased a new stake in shares of Guardian Pharmacy Services during the fourth quarter worth $30,000. BNP Paribas Financial Markets purchased a new stake in shares of Guardian Pharmacy Services during the fourth quarter worth $37,000. Compass Financial Services Inc purchased a new stake in shares of Guardian Pharmacy Services during the fourth quarter worth $58,000. JPMorgan Chase & Co. purchased a new stake in shares of Guardian Pharmacy Services during the fourth quarter worth $77,000. Finally, Quantbot Technologies LP purchased a new stake in shares of Guardian Pharmacy Services during the fourth quarter worth $81,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.